Skip to content

Clinical trials

Completed Amyloid Neuropathies, Familial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloid Neuropathies, Familial Status: Completed Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20133
20142
20152
20162
20171
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals5
Pfizer3
Ionis Pharmaceuticals, Inc.2
Boston University1
Eidos Therapeutics, a BridgeBio company1
Intellia Therapeutics1
Lantheus Germany GmbH1
Marianna Fontana1
Queen Mary University of London1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloid Neuropathies, Familial17
Amyloidosis10
Alzheimer Disease5
Amyloidosis, Familial4
Amyloid Neuropathies3
Cardiomyopathies3
Polyneuropathies2
Aortic Valve Stenosis1
Arrhythmias, Cardiac1
Death, Sudden, Cardiac1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.